Back
Delegates Premium Access

Changes in cardiorespiratory fitness, cardiovascular risk factors and patient reported outcomes in long-term breast cancer survivors after 5 months of aerobic exercise: a randomized controlled trial

Session: Shaping the future of heart health after cancer
Topic: Stratification, Prevention and Monitoring
Speaker: Doctor S. Sarvari (Oslo, NO)
Event: ESC Cardio-Oncology 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Sebastian Imre Sarvari

Oslo University Hospital Rikshospitalet, Oslo (Norway)
0 follower

5 more presentations in this session

Long-term exercise adherence and body composition after completion of an intense resistance training regimen during and after treatment for breast cancer

Speaker: Associate Professor C. Champ (Pittsburgh, US)

Access
Abstract
Slides
Like
Thumbnail

Deciphering therapy-related cardiac damage and late effects in pediatric cancer survivors

Speaker: Doctor I. Bojti (Freiburg, DE)

Access
Abstract
Slides
Like
Thumbnail

Looking beyond LVEF: cardiac and skeletal muscle function in long-term breast cancer survivors with normal versus reduced peak oxygen uptake

Speaker: Professor M. Haykowsky (Edmonton, CA)

Access
Abstract
Slides
Like
Thumbnail

An analysis of the orthostatic blood pressure changes in cancer patients

Speaker: Mr M. Iwanski (Rzeszow, PL)

Access
Abstract
Slides
Like
Thumbnail

A survey on pediatric cardio-oncology among AIEOP centers: insights moving towards a common practice.

Speaker: Doctor A. Pozza (Padova, IT)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Shaping the future of heart health after cancer

Speakers: Doctor S. Sarvari, Associate Professor C. Champ, Doctor I. Bojti, Professor M. Haykowsky, Mr M. Iwanski...
Access
Like
Thumbnail

About the event

Image

ESC Cardio-Oncology 2025

20 June - 21 June 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novartis Explore sponsored resources
logo Novo Nordisk Explore sponsored resources